Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Darya Kuplevatskaya"'
Autor:
Anton Barchuk, Anna Bulina, Mikhail Cherkashin, Natalia Berezina, Tatyana Rakova, Darya Kuplevatskaya, Dmitriy Skougarevskiy, Artemiy Okhotin
Publikováno v:
Respiratory Research, Vol 23, Iss 1, Pp 1-9 (2022)
Abstract Background Monitoring vaccine effectiveness (VE) remains a priority for epidemiological research throughout the COVID-19 pandemic. VE against infection declines with the emergence of new SARS-CoV-2 variants of concern (VOC), but VE against t
Externí odkaz:
https://doaj.org/article/68bbd209f1c745b68625008fec384e9e
Autor:
Anton Barchuk, Anna Bulina, Mikhail Cherkashin, Natalia Berezina, Tatyana Rakova, Darya Kuplevatskaya, Oksana Stanevich, Dmitriy Skougarevskiy, Artemiy Okhotin
Publikováno v:
BMC Public Health, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Studies of mRNA and vector-based vaccines used in different countries report acceptable levels of effectiveness against SARS-CoV-2 infection caused by the Delta variants of SARS-CoV-2. No studies estimated vaccine effectiveness (V
Externí odkaz:
https://doaj.org/article/6e0d401f70344c028a10b06edcf11bc7
Autor:
Anton Barchuk, Mikhail Cherkashin, Anna Bulina, Natalia Berezina, Tatyana Rakova, Darya Kuplevatskaya, Oksana Stanevich, Dmitriy Skougarevskiy, Artemiy Okhotin
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-8 (2022)
Abstract Background The results of a randomised trial showed the safety and efficacy of Gam-COVID-Vac against COVID-19. However, compared to other vaccines used across the globe, the real-world data on the effectiveness of Gam-COVID-Vac, especially a
Externí odkaz:
https://doaj.org/article/cd6635c92c3c43c1b40e9358bf952799
Autor:
Anton Barchuk, Anna Bulina, Mikhail Cherkashin, Natalia Berezina, Tatyana Rakova, Darya Kuplevatskaya, Dmitriy Skougarevskiy, Artemiy Okhotin
Background: Monitoring vaccine effectiveness (VE) remains a priority for epidemiological research throughout the COVID-19 pandemic. VE against infection declines with the emergence of new SARS-CoV-2 variants of concern, but VE against the severe dise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::acbe3f4ad2a1733bde7c16a6dc145a67
https://doi.org/10.21203/rs.3.rs-1709300/v1
https://doi.org/10.21203/rs.3.rs-1709300/v1
Autor:
Anton Barchuk, Anna Bulina, Mikhail Cherkashin, Natalia Berezina, Tatyana Rakova, Darya Kuplevatskaya, Oksana Stanevich, Dmitriy Skougarevskiy, Artemiy Okhotin
BackgroundStudies of mRNA and vector-based vaccines used in different countries report acceptable levels of effectiveness against SARS-CoV-2 infection caused by the Delta variants of SARS-CoV-2. No studies estimated vaccine effectiveness (VE) of Gam-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38901fc63b943b01c364f7de95346f1b
https://doi.org/10.1101/2022.01.24.22269714
https://doi.org/10.1101/2022.01.24.22269714